Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
300255.SZ
#2976
Rank
โ‚น478.53 B
Marketcap
โ‚น520.68
Share price
-0.42%
Change (1 day)
N/A
Change (1 year)

Revenue for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)

Revenue in 2025 (TTM): โ‚น11.31 Billion

According to Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s latest financial reports the company's current revenue (TTM ) is โ‚น12.43 Billion. In 2024 the company made a revenue of โ‚น12.27 Billion a decrease over the revenue in the year 2023 that were of โ‚น16.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น11.31 B-7.76%
2024 โ‚น12.27 B-26.28%
2023 โ‚น16.64 B-41.81%
2022 โ‚น28.60 B-16.46%
2021 โ‚น34.23 B35.06%
2020 โ‚น25.34 B19.04%
2019 โ‚น21.29 B23.27%
2018 โ‚น17.27 B26.86%
2017 โ‚น13.61 B19.62%
2016 โ‚น11.38 B18.04%
2015 โ‚น9.64 B15.9%
2014 โ‚น8.32 B17.11%
2013 โ‚น7.10 B41.72%
2012 โ‚น5.01 B43.83%
2011 โ‚น3.48 B